Aspirin. The wonder drug for melanoma?

[Gracie]

Melanoma Risk Drops 21 Percent in Women Who Take Aspirin, a New Study Finds - Skin Cancer Center - Everyday Health

 

[Mad Scientist]

Aspirin good for everything else but headache. Why people follow Western Medicine and Pharmaceutical Company?

 

[waltky]

Keytruda is very expensive...

US Regulators Approve New Cancer Drug with Novel Action
September 05, 2014 WASHINGTON — The U.S. Food and Drug Administration this week gave the green light to the pharmaceutical company Merck’s anti-cancer compound Keytruda, a novel drug designed to fight advanced melanoma.

Keytruda has a unique action, enlisting the body’s immune response against the lethal cancer. Normally, cancerous tumors disarm the immune system. But Keytruda inhibits the action of one of the proteins tumors use to block immune response.

Known generically as pembrolizumab, the drug reportedly is safe with few side effects. Conventional chemotherapy drugs target fast-growing cancer cells and can cause disabling side effects. Cancer experts have been anxiously awaiting speedy regulatory approval of a new drug to fight the deadliest form of skin cancer. The FDA gave speedy approval to Keytruda after a large, phase one safety trial.

In a study involving 173 patients, distant tumors from the original cancer shrank in about a quarter of cases. The positive effect lasted up to eight-and-a-half months. But Keytruda is very expensive. Merck has set the price of the drug at more than $12,000 per month. A year’s worth of treatment with Keytruda adds up to around $150,000.

US Regulators Approve New Cancer Drug with Novel Action

 

[Delta4Embassy]

Melanoma Risk Drops 21 Percent in Women Who Take Aspirin, a New Study Finds - Skin Cancer Center - Everyday Health

Started a daily low-dose of aspirin a couple years ago after hearing about studies showing a third less chance of certain cancers after 5 years on the regime. Caffeine's good too for melanoma,

Can google caffeine skin cancer and read about it.

 

[Casjah]

Keytruda is very expensive...

US Regulators Approve New Cancer Drug with Novel Action
September 05, 2014 WASHINGTON — The U.S. Food and Drug Administration this week gave the green light to the pharmaceutical company Merck’s anti-cancer compound Keytruda, a novel drug designed to fight advanced melanoma.

Keytruda has a unique action, enlisting the body’s immune response against the lethal cancer. Normally, cancerous tumors disarm the immune system. But Keytruda inhibits the action of one of the proteins tumors use to block immune response.

Known generically as pembrolizumab, the drug reportedly is safe with few side effects. Conventional chemotherapy drugs target fast-growing cancer cells and can cause disabling side effects. Cancer experts have been anxiously awaiting speedy regulatory approval of a new drug to fight the deadliest form of skin cancer. The FDA gave speedy approval to Keytruda after a large, phase one safety trial.

In a study involving 173 patients, distant tumors from the original cancer shrank in about a quarter of cases. The positive effect lasted up to eight-and-a-half months. But Keytruda is very expensive. Merck has set the price of the drug at more than $12,000 per month. A year’s worth of treatment with Keytruda adds up to around $150,000.

US Regulators Approve New Cancer Drug with Novel Action

I can't imagine Pharma will make much of a profit curing disease. No one can pay these prices except the super rich, so I believe this new wonder drug will disappear into obscurity like the others. This particular method for treating cancer is not new.